The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sung, B., Park, B., Yadav, V. R., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090209 · Cited by 123
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Self-citationLang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Heat shock, stress proteins, chaperones, and proteotoxicity
Hightower, L. E. (1991) · Cell · doi:10.1016/0092-8674(91)90611-2 · Cited by 1,059
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
NF- B as a Critical Link Between Inflammation and Cancer
Karin, M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000141 · Cited by 816
Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.689 · Cited by 722
Dustin, M. L., Singer, K. H., Tuck, D. T., & Springer, T. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1323 · Cited by 669
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Pathways connecting inflammation and cancer
Allavena, P., Garlanda, C., Borrello, M. G., Sica, A., & Mantovani, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.003 · Cited by 437
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
Westerheide, S. D., Bosman, J. D., Mbadugha, B. N. A., Kawahara, T. L. A., Matsumoto, G., Kim, S., Gu, W., Devlin, J. P., Silverman, R. B., & Morimoto, R. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409267200 · Cited by 427
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417
Self-citationMolecular Pathways Linking Inflammation and Cancer
Mantovani, A. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316968 · Cited by 414
Replicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Self-citationAllison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00192-0 · Cited by 376
Blasko, I., Stampfer‐Kountchev, M., Robatscher, P., Veerhuis, R., Eikelenboom, P., & Grubeck‐Loebenstein, B. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00101.x · Cited by 374
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Zhang, T., Hamza, A., Cao, X., Wang, B., Yu, S., Zhan, C.-G., & Sun, D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0484 · Cited by 363
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Self-citationChemokines in asthma: Cooperative interaction between chemokines and IL-13
Rosenwasser, L. J., Zimmermann, N., Hershey, G. K., Foster, P. S., & Rothenberg, M. E. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.139 · Cited by 331
Lee, J.-H., Koo, T. H., Yoon, H., Jung, H. S., Jin, H. Z., Lee, K., Hong, Y.-S., & Lee, J. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.014 · Cited by 308
Celastrol: Molecular targets of Thunder God Vine
Salminen, A., Lehtonen, M., Paimela, T., & Kaarniranta, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.050 · Cited by 293
Tao, X., Younger, J., Fan, F. Z., Wang, B., & Lipsky, P. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10411 · Cited by 282
Therapeutic and diagnostic implications of Hsp90 activation
Kamal, A., Boehm, M. F., & Burrows, F. J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.006 · Cited by 278
Inflammation: A pivotal link between autoimmune diseases and atherosclerosis
Abou-Raya, A., & Abou-Raya, S. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.12.006 · Cited by 264
Barker, J. N., Sarma, V, Mitra, R. S., Dixit, V. M., & Nickoloff, B. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114481 · Cited by 261
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
Balkwill, F., & Mantovani, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.312 · Cited by 249
Molecular and cellular mechanisms of allergic disease☆☆☆
Broide, D. H. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.116436 · Cited by 244
Pang, X., Yi, Z., Zhang, J., Lu, B., Sung, B., Qu, W., Aggarwal, B. B., & Liu, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3201 · Cited by 216
Celastrol protects against MPTP‐ and 3‐nitropropionic acid‐induced neurotoxicity
Cleren, C., Calingasan, N. Y., Chen, J., & Beal, M. F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03253.x · Cited by 207
Kiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N. Y., & Beal, M. F. (2005) · Neurodegenerative Diseases · doi:10.1159/000090364 · Cited by 199
Hassane, D. C., Guzman, M. L., Corbett, C., Li, X., Abboud, R., Young, F., Liesveld, J. L., Carroll, M., & Jordan, C. T. (2008) · Blood · doi:10.1182/blood-2007-11-126003 · Cited by 185
Models for prevention and treatment of cancer: Problems vs promises
Aggarwal, B. B., Danda, D., Gupta, S., & Gehlot, P. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.027 · Cited by 179
Potential pharmacological control of the NF-κB pathway
Sethi, G., & Tergaonkar, V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.004 · Cited by 171
Self-citationFaust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 168
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
Paris, D., Ganey, N. J., Laporte, V., Patel, N. S., Beaulieu-Abdelahad, D., Bachmeier, C., March, A., Ait-Ghezala, G., & Mullan, M. J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-17 · Cited by 168
Jin, H. Z., Hwang, B. Y., Kim, H. S., Lee, J. H., Kim, Y. H., & Lee, J. J. (2002) · Journal of Natural Products · doi:10.1021/np010428r · Cited by 153
Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsies
Pinna, G., Fiorucci, M., Reimund, J., Taquet, N., Arondel, Y., & Muller, C. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.186 · Cited by 141
Jung, H. W., Chung, Y. S., Kim, Y. S., & Park, Y. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.78 · Cited by 137
Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-κB-mediated pathway
Hozumi, A., Nishimura, Y., Nishiuma, T., Kotani, Y., & Yokoyama, M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.6.l1444 · Cited by 130
Liang, K., Lee, C., Lin, W., Lin, C., Wu, C., Luo, S., & Yang, C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20992 · Cited by 128
Huang, Y., Zhou, Y., Fan, Y., & Zhou, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.043 · Cited by 122
Pasinetti, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00113-3 · Cited by 115
Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.661 · Cited by 115
Kim, D. H., Shin, E. K., Kim, Y. H., Lee, B. W., Jun, J., Park, J. H., & Kim, J.-K. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02186.x · Cited by 114
Idris, A. I., Libouban, H., Nyangoga, H., Landao‐Bassonga, E., Chappard, D., & Ralston, S. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0133 · Cited by 112
Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol
Nagase, M., Jinsei, O. T. O., SUGIYAMA, S., Yube, K., Takaishi, Y., & Sakato, N. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.1883 · Cited by 108
Peng, B., Xu, L., Cao, F., Wei, T., Yang, C., Uzan, G., & Zhang, D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-79 · Cited by 104
Lu, Z., Jin, Y., Qiu, L., Lai, Y., & Pan, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.006 · Cited by 103
Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma
Abbas, S., Bhoumik, A., Dahl, R. S., Vasile, S., Krajewski, S., Cosford, N. D. P., & Ronai, Z. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1536 · Cited by 101
Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model
Kim, D. Y., Park, J., Jeoung, D., & Ro, J. Y. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.078 · Cited by 100
The triterpene celastrol as a very potent inhibitor of lipid peroxidation in mitochondria
SASSA, H., Takaishi, Y., & Terada, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90759-g · Cited by 97
Antiangiogenic activity of Tripterygium wilfordii and its terpenoids
He, M.-F., Liu, L., Ge, W., Shaw, P., Jiang, R., Wu, L., & But, P. P.-H. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.033 · Cited by 96
Chadli, A., Felts, S. J., Wang, Q., Sullivan, W. P., Botuyan, M. V., Fauq, A., Ramirez-Alvarado, M., & Mer, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081018 · Cited by 94
Yadav, V. R., Sung, B., Prasad, S., Kannappan, R., Cho, S., Liu, M., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0669-3 · Cited by 90
Yu, X., Tao, W., Jiang, F., Li, C., Lin, J., & Liu, C. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.75 · Cited by 86
Celastrol Potentiates Radiotherapy by Impairment of DNA Damage Processing in Human Prostate Cancer
Dai, Y., DeSano, J. T., Meng, Y., Ji, Q., Ljungman, M. E., Lawrence, T. S., & Xu, L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.057 · Cited by 83
Induction of heat shock proteins in differentiated human and rodent neurons by celastrol
Chow, A. M., & Brown, I. R. (2005) · Cell Stress and Chaperones · doi:10.1379/csc-269.1 · Cited by 83
He, D., Xu, Q., Yan, M., Zhang, P., Zhou, X., Zhang, Z., Duan, W., Zhong, L., Ye, D., & Chen, W. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-343 · Cited by 78
Therapeutic effect of tripterine on adjuvant arthritis in rats
Li, H., Zhang, Y., Tan, H., Jia, Y., & Li, D. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.05.028 · Cited by 72
LIN, C., TSENG, H., HSIEH, H., LEE, C., WU, C., CHENG, C., & YANG, C. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.032 · Cited by 65
Blouin, S., Baslé, M. F., & Chappard, D. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9002-5 · Cited by 64
Celastrol binds to ERK and inhibits FcεRI signaling to exert an anti-allergic effect
Kim, Y.-M., Kim, K., Lee, H., Han, S., Lee, Y., Choe, J., Kim, Y.-M., Hahn, J.-H., Ro, J. Y., & Jeoung, D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.071 · Cited by 64
Zhu, H., Liu, X.-W., Cai, T.-Y., Cao, J., Tu, C.-X., Lu, W. P., He, Q.-J., & Yang, B. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165654 · Cited by 62
SASSA, H., Kogure, K., Takaishi, Y., & Terada, H. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90075-2 · Cited by 61
Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study.
Zhou, Y.-X., & Huang, Y.-L. (2009) · PubMed · Cited by 61
Tripterine inhibits the expression of adhesion molecules in activated endothelial cells
Zhang, D., Marconi, A., Xu, L., Yang, C., Sun, G.-W., Feng, X., Ling, C., Qin, W.-Z., Uzan, G., & d’Alessio, P. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005611 · Cited by 60
Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol
Zhu, H., Ding, W., Wu, R. F., Weng, Q., Lou, J.-S., Jin, R., Lu, W. P., Yang, B., & He, Q. (2009) · Cancer Investigation · doi:10.3109/07357900903095664 · Cited by 59
Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
Sogno, I., Vannini, N., Lorusso, G., Cammarota, R., Noonan, D. M., Generoso, L., Sporn, M. B., & Albini, A. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_19 · Cited by 58
Celastrol causes apoptosis and cell cycle arrest in rat glioma cells
Ge, P., Ji, X., Ding, Y., Wang, X., Fu, S., Meng, F., Jin, X., Ling, F., & Luo, Y. (2009) · Neurological Research · doi:10.1179/016164109x12518779082273 · Cited by 58
Idris, A. I., Krishnan, M., Šimić, P., Landao‐Bassonga, E., Mollat, P., Vukičević, S., & Ralston, S. H. (2010) · The FASEB Journal · doi:10.1096/fj.10-164095 · Cited by 58
Zhu, H., Liu, X.-W., Ding, W.-J., Xu, D.-Q., Zhao, Y.-C., Lu, W. P., He, Q.-J., & Yang, B. Y. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.030 · Cited by 57
Wang, J., Gigliotti, F., Bhagwat, S. P., Maggirwar, S. B., & Wright, T. W. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00452.2006 · Cited by 54
Neuhaus, T., Pabst, S., Stier, S., Weber, A., Schrör, K., Sachinidis, A., Vetter, H., & Ko, Y. D. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.029 · Cited by 53
Lee, Y., Tran, H. T. L., & Ta, Q. V. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.4.029 · Cited by 52
Walcott, S. E., & Heikkila, J. J. (2010) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2010.02.015 · Cited by 48
Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells
Chen, M., Rose, A. E., Doudican, N. A., Osman, I., & Orlow, S. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0243 · Cited by 47
Massioui, N. E., Ouary, S., Chéruel, F., Hantraye, P., & Brouillet, E. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7766 · Cited by 45
Synthesis and preliminary evaluation of neuroprotection of celastrol analogues in PC12 cells
Sun, H., Xu, L., Yu, P., Jiang, J., Zhang, G., & Wang, Y. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.066 · Cited by 44
Targeting the UPS as therapy in multiple myeloma
Chauhan, D., Bianchi, G., & Anderson, K. C. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s1 · Cited by 43
Celastrol: A New Therapeutic Potential of Traditional Chinese Medicine
Morita, T. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.87 · Cited by 42
Pham, A., Blower, P. E., Alvarado, O., Ravula, R., Gout, P. W., & Huang, Y. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162248 · Cited by 37
Seo, W. Y., Ju, S. M., Song, H. Y., Goh, A. R., Jun, J., Kang, Y., Choi, S. Y., & Park, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.053 · Cited by 29
Zhang, D., Xu, L., Cao, F., Wei, T., Yang, C., Uzan, G., & Peng, B. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0202-1 · Cited by 28
Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation
Wu, F. Y., Han, M. H., & Wilson, J. X. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00292.x · Cited by 27
Celastrol, a Triterpene Extracted From Tripterygium wilfordii Hook F, Inhibits Platelet Activation
Hu, H., Straub, A., Tian, Z., Bassler, N., Cheng, J., & Peter, K. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181b21472 · Cited by 26
Inhibition of Anthrax Lethal Toxin-Induced Cytolysis of RAW264.7 Cells by Celastrol
Chapelsky, S., Batty, S., Frost, M., & Mogridge, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001421 · Cited by 22
Cancer angiogenesis: Targeting the heel of Achilles
Dass, C. R., & Choong, P. (2008) · Journal of drug targeting · doi:10.1080/10611860802088523 · Cited by 19
Nakamichi, K., Kitani, H., Takayama‐Ito, M., Morimoto, K., Kurane, I., & Saijo, M. (2010) · International Journal of Neuroscience · doi:10.3109/00207451003615763 · Cited by 14
Heat shock proteins: A broader perspective
Moseley, P. L. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90021-9 · Cited by 9
Cited by
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationTargeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Self-citationPlant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
Jantan, I., Ahmad, W., & Bukhari, S. N. A. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00655 · Cited by 409
Liby, K. T., & Sporn, M. B. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004846 · Cited by 405
Targeting autophagy using natural compounds for cancer prevention and therapy
Deng, S., Shanmugam, M. K., Kumar, A. P., Yap, C. T., Sethi, G., & Bishayee, A. (2019) · Cancer · doi:10.1002/cncr.31978 · Cited by 320
Self-citation
Metadata
- Authors
- Kannaiyan, R., Shanmugam, M. K., & Sethi, G.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2011-04-01
- Volume
- 303
- Issue
- 1
- Pages
- 9-20
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2152180560
- Cited by
- 346
- References
- 103
- FWCI
- 41.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.